Lifestance Health Group, Inc. (LFST) — SEC Filings
Lifestance Health Group, Inc. (LFST) — 27 SEC filings. Latest: DEFA14A (Apr 22, 2026). Includes 11 8-K, 6 10-Q, 6 SC 13G/A.
View Lifestance Health Group, Inc. on SEC EDGAR
Overview
Lifestance Health Group, Inc. (LFST) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 6, 2025: LifeStance Health Group, Inc. reported a significant turnaround in its financial performance for the three months ended September 30, 2025, achieving a net income of $1.077 million, a substantial improvement from a net loss of $5.957 million in the same period of 2024. Total revenue increased by 16.
Sentiment Summary
Across 27 filings, the sentiment breakdown is: 1 bullish, 25 neutral, 1 mixed. The dominant filing sentiment for Lifestance Health Group, Inc. is neutral.
Filing Type Overview
Lifestance Health Group, Inc. (LFST) has filed 1 DEFA14A, 6 10-Q, 11 8-K, 2 DEF 14A, 1 10-K, 6 SC 13G/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (27)
Risk Profile
Risk Assessment: Of LFST's 20 recent filings, 0 were flagged as high-risk, 12 as medium-risk, and 8 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $363,809,000 |
| Net Income | $1,077,000 |
| EPS | $0.00 |
| Debt-to-Equity | 0.45 |
| Cash Position | $203,903,000 |
| Operating Margin | N/A |
| Total Assets | $2,148,969,000 |
| Total Debt | $269,392,000 |
Key Executives
- David M. Shane
- Dr. Michelle R. Riba
- Dr. Robert L. T. Smith
- Kenneth Burdick
- Dr. David Snow
- Ms. Jennifer Choe
- Dr. Deonanza
- Mr. Ryan
- Michael K. Lester
- Ms. Jennifer Choe-Smith
- Abigail P. Johnson
Industry Context
LifeStance operates in the rapidly growing but fragmented mental health services sector. The industry is characterized by increasing demand for accessible care, driven by greater awareness and reduced stigma. However, it faces challenges related to provider shortages, reimbursement complexities, and evolving regulatory landscapes.
Top Tags
executive-compensation (6) · 10-Q (4) · financials (4) · healthcare (4) · board-changes (3) · amendment (3) · Mental Health (2) · Healthcare Services (2) · Revenue Growth (2) · shareholder-vote (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Total Revenue (Q3 2025) | $363.809M | Increased by 16.3% from $312.722 million in Q3 2024 |
| Net Income (Q3 2025) | $1.077M | Swing from a net loss of $5.957 million in Q3 2024 |
| Net Loss (YTD Q3 2025) | $2.005M | Reduced from a net loss of $50.331 million in YTD Q3 2024 |
| Cash and Cash Equivalents (Sept 30, 2025) | $203.903M | Increased from $154.571 million at Dec 31, 2024 |
| Net Cash Provided by Operating Activities (YTD Q3 2025) | $88.591M | Increased from $44.944 million in YTD Q3 2024 |
| Long-term Debt, net (Sept 30, 2025) | $269.392M | Decreased from $279.790 million at Dec 31, 2024 |
| Common Stock Shares Outstanding (Oct 29, 2025) | 389,000,281 | Reflects shares outstanding as of a recent date |
| Diluted EPS (Q3 2025) | $0.00 | Improved from -$0.02 in Q3 2024 |
| Q2 2025 Patient Service Revenue | $290.0M | Increased from $250.0M in Q2 2024, showing 16% growth. |
| YTD Patient Service Revenue (June 30, 2025) | $570.0M | Represents total revenue for the first six months of 2025. |
| Top Payor Revenue Concentration | 10% | Indicates significant reliance on a single customer for the first half of 2025. |
| Commercial Payor Revenue Contribution | 80% | Portion of Q2 2025 patient service revenue from commercial sources. |
| Debt Facility | 2024 Credit Agreement | Established December 19, 2024, impacting capital structure and liquidity. |
| SEC File Number | 001-40478 | Identifies the company's filing history with the SEC. |
| IRS Employer Identification No. | 86-1832801 | Company's tax identification number. |
Forward-Looking Statements
- {"claim":"FMR LLC will maintain a significant ownership stake in LifeStance Health Group, Inc. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-12","confidence":"high"}
- {"claim":"FMR LLC will maintain a significant ownership stake in LifeStance Health Group, Inc. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Lifestance Health Group, Inc. (LFST)?
Lifestance Health Group, Inc. has 27 recent SEC filings from Jan 2024 to Apr 2026, including 11 8-K, 6 10-Q, 6 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LFST filings?
Across 27 filings, the sentiment breakdown is: 1 bullish, 25 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Lifestance Health Group, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Lifestance Health Group, Inc. (LFST) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Lifestance Health Group, Inc.?
Key financial highlights from Lifestance Health Group, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for LFST?
The investment thesis for LFST includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Lifestance Health Group, Inc.?
Key executives identified across Lifestance Health Group, Inc.'s filings include David M. Shane, Dr. Michelle R. Riba, Dr. Robert L. T. Smith, Kenneth Burdick, Dr. David Snow and 6 others.
What are the main risk factors for Lifestance Health Group, Inc. stock?
Of LFST's 20 assessed filings, 0 were flagged high-risk, 12 medium-risk, and 8 low-risk.
What are recent predictions and forward guidance from Lifestance Health Group, Inc.?
Recent forward-looking statements from Lifestance Health Group, Inc. include guidance on {"claim":"FMR LLC will maintain a significant ownership stake in LifeStance Health Group, Inc. for the foreseeable futur and 1 other predictions.